Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-13

Clinical Trial Update: Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population [NA]

View source ↗

Summary

Clinical trial evaluating Senofilcon A with a new UV-blocker in a population with visual acuity outcomes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Senofilcon A

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Acuity | NA | Status: COMPLETED | Results posted: 2020-03-13